Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa

被引:65
|
作者
Gaziano, T. A. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
关键词
D O I
10.1136/hrt.2007.128785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death in those over the age of 45 in Africa. The economic toll from cardiovascular diseases is equally devastating, leading to billions of dollars lost due to healthcare costs and reduced productivity from the disabling and fatal outcomes related to diabetes, hypertension, stroke, valvular heart disease, and heart failure. Much of it is preventable. With reasonable screening programmes and judicious use of scarce resources much of the suffering can be alleviated. This article reviews the economic burden attributable to cardiovascular disease in Africa and many of the potential cost-effective solutions to the large burden. It further outlines many of the areas where we know less and must focus our future research in trying to outline cost-effective solutions.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of educational preventive technologies for patients with cardiovascular diseases in Russia
    Kontsevaya, A.
    Kalinina, A.
    VALUE IN HEALTH, 2008, 11 (03) : A198 - A199
  • [32] The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review
    Jiang, Xinchan
    Ming, Wai-Kit
    You, Joyce H. S.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (06)
  • [33] Cost-effectiveness of lowering systolic blood pressure in reducing cardiovascular disease burden in Australia
    Cho, Haeri
    Lee, Jinkyeong
    Cao, Alison
    Leong, Grant Choo Way
    Chenh, Kathryn
    Abushanab, Dina
    Marquina, Clara
    Professor, Zanfina Ademi
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (12)
  • [34] Cost-Effectiveness of Cardiovascular Disease Spending
    Miller, George
    Cohen, Joshua T.
    Roehrig, Charles
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2123 - 2124
  • [35] Cost-effectiveness Considerations of Cardiovascular Therapeutics
    Keech, Anthony
    Horowitz, John D.
    HEART LUNG AND CIRCULATION, 2009, 18 (02): : 118 - 122
  • [36] Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease A Cost-Effectiveness Analysis
    Smith-Spangler, Crystal M.
    Juusola, Jessie L.
    Enns, Eva A.
    Owens, Douglas K.
    Garber, Alan M.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (08) : 481 - U21
  • [37] COST-EFFECTIVENESS OF RARE DISEASES IN SPAIN
    Pomares, E.
    Uria, E.
    Martinez-Rodriguez, I
    Cuesta, M.
    VALUE IN HEALTH, 2018, 21 : S454 - S454
  • [38] Cost-Effectiveness of Biologics for Allergic Diseases
    Wu, Ann Chen
    Fuhlbrigge, Anne L.
    Robayo, Maria Acosta
    Shaker, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1107 - +
  • [39] Cost-effectiveness analysis in infectious diseases
    Paul, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (12) : 1705 - 1706
  • [40] The Economic Burden of Somatization Syndromes: A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses
    Konnopka, Alexander
    Schaefert, Rainer
    Heinrich, Sven
    Leicht, Hanna
    Kaufmann, Claudia
    Luppa, Melanie
    Herzog, Wolfgang
    Koenig, Hans-Helmut
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2011, 14 : S16 - S17